Australia · 
Who invested in AdvanCell?
AdvanCell's investors include Abingworth, Sanofi Ventures, Morningside Group, SV Health Investors and Brandon Capital, and 15 more on record. Ally Bridge Group led its latest round.
2026
$112MSeries C$11MGrant$315MSeries D
Australia · Series D startup
Who invested in AdvanCell
3 rounds we have observed, with the 20 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 4 months ago
Follow AdvanCell and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$438Mraised across 3 rounds since 2025, from 4 sources
$112MSeries C$11MGrant$315MSeries D
- Latest round
- Series D, $315MJul 2026
- Led by
- Ally Bridge Group and Alpha Wave
- Step-upi
- 27.9×
- Investors
- 20 (6 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series C, $112M Feb 2025
- Biggest round
- $315M Series D · Jul 2026
- Usual gap between rounds
- 15 months the median of 2
The rounds
- Jul 2026Series D$315M11 new6 returning
Ally Bridge GroupLead- Alpha WaveLead
Fidelity
Morningside Group
Eli Lilly
T. Rowe Price
Catalio Capital Management
Abingworth
Alpha Wave Global
SV Health Investors
Bain Capital- Bain Capital Life Sciences
Brandon Capital
Sanofi Ventures
Eventide Asset Management
Tenmile
Velosity Capital
Reported by QRM Capital and 1 otherSEC filing: $218M sold
- Apr 2025
- Feb 2025Series C$112M7 new
- AbingworthLead
- Sanofi VenturesLead
SymBiosisLead
SV Health InvestorsLead- Morningside Group
- Brandon Capital
- Tenmile
Reported by Startup Daily
Founders and team
From AdvanCell's own website: 16 on the team.
- Philina LeeChief Executive Officer
- Anna KarmannChief Medical Officer
- Dayle HoggChief Operating Officer (Consulting)
- François GaudetChief Technology Officer
- Justyna KellyChief Technology Officer
- Matthew VincentChief Scientific Officer
- Sean CassidyChief Operating Officer (Consulting)
- Simon PuttickChief Isotope Development Officer
- Andrew KayChair
- Andrew LamDirector
- Anthony AiudiDirector
- Bali MuralidharDirector
- Christopher GagliardiDirector
- Jamil BegDirector
- Kevin CameronDirector
- Nik EconomopoulosDirector
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series C2025Grant2025Series D2026AbingworthLSanofi VenturesLMorningside GroupSV Health InvestorsBrandon CapitalTenmileAlly Bridge GroupLAlpha WaveLSymBiosisLSV Health InvestorsL
AbingworthLSanofi VenturesLMorningside GroupSV Health InvestorsBrandon CapitalTenmileAlly Bridge GroupLAlpha WaveLSymBiosisLSV Health InvestorsLEveryone who backed them
Alpha WavePrivate equity1round, led 1
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about AdvanCell
How much has AdvanCell raised?
AdvanCell has raised $438M across 3 rounds since 2025.
When did AdvanCell last raise?
AdvanCell's most recent round was a Series D of $315M in Jul 2026, led by Ally Bridge Group.
What was AdvanCell's biggest round?
Its most recent round, $315M in Jul 2026, is also its largest on record.
Who backed AdvanCell first?
AdvanCell's first round on record, in Feb 2025, was backed by Abingworth, Sanofi Ventures and SymBiosis and 4 others.
What stage is AdvanCell at?
AdvanCell's latest named round is a Series D, in Jul 2026.
Where is AdvanCell based?
AdvanCell is based in Australia.
Who led AdvanCell's rounds?
Abingworth led the Series C in 2025; Ally Bridge Group led the Series D in 2026.
Companies like AdvanCell
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.